MONTHLY WEBINAR SERIES

COVID-19 RESOURCES

IMAGINE

WILL TRANSFORM THE MANAGEMENT OF IBD AND IBS AND ASSOCIATED MENTAL HEALTH ISSUES WITH THESE DISORDERS. TO PARTICIPATE IN OUR MAGIC STUDY CLICK HERE.

IMAGINE

AIMS TO FIND NEW THERAPIES FOR THE TREATMENT OF IBS, IBD, AND ASSOCIATED PSYCHIATRIC DISORDERS. READ ABOUT OUR CURRENT RESEARCH SUB-STUDIES HERE.

IMAGINE

IS THE FUTURE OF HEALTH. READ ABOUT OUR PATIENT RESEARCH PARTNERS AND HOW THEY ARE HELPING US PRIORITIZE THE UNIQUE NEEDS OF PATIENTS.

Learning: 

IMAGINE's Webinar Series

Want to learn about how we do our research? Click here to check out our webinar series!

Did you know that Canada has one of the highest rates of IBD and IBS disorders in the world?

People living with GI disorders have higher rates of anxiety and depression compared to the general population and patients with anxiety and depression are reported to have more GI symptoms. Learn more about the statistics in Canada and what the IMAGINE Network is by clicking here.

IMAGINE will be developing innovative therapies and novel probiotics for Irritable Bowel Syndrome (IBS) and Inflammatory Bowel Disease (IBD). We’ve been patient-driven in setting priorities for this work. We believe IBD and IBS are caused by an immune response to the disturbance in the gut’s microbiome, and we know diet plays a key role in shaping the gut microbiome.
Dr. Paul Moayyedi

Principal Investigator, IMAGINE SPOR